홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Potassium Carbonate → HCID 44125255, 화합물

HRID 1162479
인쇄

반응식

HRID 1162479 반응식
Br[C:2]1[CH:3]=[C:4]([NH:9][S:10]([C:13]2[CH:18]=[CH:17][C:16]([CH:19]([NH:21][CH3:22])[CH3:20])=[CH:15][CH:14]=2)(=[O:12])=[O:11])[C:5]([Cl:8])=[N:6][CH:7]=1.CC1(C)C(C)(C)OB([C:31]2[CH:32]=[CH:33][C:34]3[N:35]([CH:37]=[C:38]([NH:40][C:41](=[O:43])[CH3:42])[N:39]=3)[N:36]=2)O1.C(=O)([O-])[O-].[K+].[K+]>COCCOC.O.C(Cl)Cl.CO>[Cl:8][C:5]1[N:6]=[CH:7][C:2]([C:31]2[CH:32]=[CH:33][C:34]3[N:35]([CH:37]=[C:38]([NH:40][C:41](=[O:43])[CH3:42])[N:39]=3)[N:36]=2)=[CH:3][C:4]=1[NH:9][S:10]([C:13]1[CH:18]=[CH:17][C:16]([CH:19]([NH:21][CH3:22])[CH3:20])=[CH:15][CH:14]=1)(=[O:12])=[O:11]
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

8

반응물 3

HCID 11430Potassium CarbonateHCID 57749440N-(6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)imidazo[1,2-b]pyridazin-2-yl)acetamide2회HCID 57749441HCID 57749441, 화합물

생성물 1

HCID 44125255HCID 44125255, 화합물수율 42%

시약·촉매·용매 4

HCID 887Methanol용매
HCID 962
Water
용매
HCID 6344Dichloromethane용매
HCID 80711,2-Dimethoxyethane용매

실험 절차

N-(5-bromo-2-chloropyridin-3-yl)-4-(1-(methylamino)ethyl)benzenesulfonamide (488 mg, 1.21 mmol), N-(6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)imidazo[1,2-b]pyridazin-2-yl)acetamide (590.6 mg, 1.955 mmol), potassium carbonate (600 mg, 4.34 mmol), and Pd(dppf)Cl2*DCM complex (117.5 mg, 0.1439 mmol) were suspended in DME (8.0 mL) and water (2.0 mL). The reaction flask was fit with a reflux condensor and placed in a preheated oil bath (100 C) and stirred under nitrogen for 75 minutes. Then, the reaction was cooled to room temperature, and more N-(6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)imidazo[1,2-b]pyridazin-2-yl)acetamide (213 mg, 0.705 mmol) was added, and stirring was continued at 100 C. After another hour, the reaction was cooled to room temperature, diluted with DCM and MeOH, and filtered through a pad of Celite® (diatomaceous earth). The filtrate was concentrated and purified using silica gel on a filter (DCM to 50:1 to 20:1 to 5:1 to 3:1 DCM/2 N ammonia in MeOH). The fractions with product were collected, concentrated, treated with MeOH, and filtered. The solid was washed with MeOH, Et2O, DCM, MeOH, and Et2O. The solid was then collected and dried under high vacuum to afford N-(6-(6-chloro-5-(4-(1-(methylamino)ethyl)phenylsulfonamido)pyridin-3-yl)imidazo[1,2-b]pyridazin-2-yl)acetamide (253 mg, 42% yield) as a brown, amorphous solid. MS (ESI positive ion) m/z: 500 (M+1). Calcd for C22H22ClN7O3S: 499. 1H NMR (400 MHz, DMSO-d6): δ ppm 10.93 (s, 1H), 8.25 (s, 1H), 8.12-8.06 (m, 2H), 8.03 (d, J=9.54 Hz, 1H), 7.85 (d, J=8.53 Hz, 2H), 7.56-7.47 (m, 4H), 4.32-4.20 (m, 1H), 2.40 (s, 3H), 2.11 (s, 3H), 1.48 (d, J=6.53 Hz, 3H).

후처리

  1. customplaced in a preheated oil bath
  2. stirringstirring
  3. waitAfter another hour
  4. temperaturethe reaction was cooled to room temperature
  5. filtrationfiltered through a pad of Celite® (diatomaceous earth)
  6. concentrationThe filtrate was concentrated
  7. custompurified
  8. filtrationa filter (DCM to 50:1 to 20:1 to 5:1 to 3:1 DCM/2 N ammonia in MeOH)
  9. customThe fractions with product were collected
  10. concentrationconcentrated
  11. additiontreated with MeOH
  12. filtrationfiltered
  13. washThe solid was washed with MeOH, Et2O, DCM, MeOH, and Et2O
  14. customThe solid was then collected
  15. customdried under high vacuum

출처 및 근거

ORD 기록
ord-06c834916eb64fa88d841e8d7688a169
출처 데이터셋
uspto-grants-2010_10
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US07820665B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트